Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. It is developing VYN202, an oral, small molecule BD2-selective BET inhibitor. VYN202 is an oral, small molecule BD2-selective BET inhibitor that has been designed to achieve potential class-leading potency and selectivity for BD2 vs. BD1. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating. more
| Time Frame | YARW | S&P500 | |
|---|---|---|---|
| 1-Week Return | 3042.15%% | % | -1.24%% |
| 1-Month Return | 4232.05%% | % | -0.25%% |
| 3-Month Return | 4215.38%% | % | 3.83%% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| YARW | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| YARW | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
Yarrow Bioscience Inc (YARW) share price today is $28.05
Yes, Indians can buy shares of Yarrow Bioscience Inc (YARW) on Vested. To buy
Yes, you can purchase fractional shares of Yarrow Bioscience Inc (YARW) via the Vested app. You can start investing in Yarrow Bioscience Inc (YARW) with a minimum investment of $1.
You can invest in shares of Yarrow Bioscience Inc (YARW) via Vested in three simple steps:
The 52-week high price of Yarrow Bioscience Inc (YARW) is $28.56. The 52-week low price of Yarrow Bioscience Inc (YARW) is $0.47.
The price-to-earnings (P/E) ratio of Yarrow Bioscience Inc (YARW) is
The price-to-book (P/B) ratio of Yarrow Bioscience Inc (YARW) is 0.00
The dividend yield of Yarrow Bioscience Inc (YARW) is 0.00%
The market capitalization of Yarrow Bioscience Inc (YARW) is
The stock symbol (or ticker) of Yarrow Bioscience Inc is YARW
Consider the share price of Yarrow Bioscience Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Yarrow Bioscience Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Yarrow Bioscience Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Yarrow Bioscience Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Yarrow Bioscience Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Yarrow Bioscience Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied